The UK Medicines and Health Products Regulatory Agency (MRHA) authorized the use of Lagevrio (Molnupiravir), an oral antiviral developed by the US laboratory Merck, which could become a crucial tool in the fight against Covid-19.
The MRHA, a scientific, autonomous and independent advisory body of…
Read More...
